Rheumatoid arthritis - anakinra (replaced by CG79)
The clinical effectiveness and cost effectiveness of anakinra for rheumatoid arthritis
Summary
This guidance has been replaced by the clinical guideline on rheumatoid arthritis.
Guidance documents
Implementing this guidance
Other information
About this guidance
Technology appraisals TA72
Issued: November 2003
How this guidance was produced